These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 2839588)
1. Studies of possible antiidiotypic control mechanisms in Graves' disease. Moynier M; Montano J; Williams RC; Pathak D; DeGroot LC; Hill BL; Marshall NJ J Lab Clin Med; 1988 Jul; 112(1):99-108. PubMed ID: 2839588 [TBL] [Abstract][Full Text] [Related]
2. Partial characterization and clinical correlation of circulating human immunoglobulins directed against thyrotrophin binding sites in guinea pig fat cell membranes. Development of a direct enzyme immunoassay. Baker JR; Lukes YG; Smallridge RC; Berger M; Burman KD J Clin Invest; 1983 Oct; 72(4):1487-97. PubMed ID: 6138364 [TBL] [Abstract][Full Text] [Related]
3. Antithyrotropin antibodies in the sera of Graves' disease patients. Raines KB; Baker JR; Lukes YG; Wartofsky L; Burman KD J Clin Endocrinol Metab; 1985 Aug; 61(2):217-22. PubMed ID: 2989314 [TBL] [Abstract][Full Text] [Related]
4. Production, isolation, and characterization of rabbit anti-idiotypic antibodies directed against human antithyrotrophin receptor antibodies. Baker JR; Lukes YG; Burman KD J Clin Invest; 1984 Aug; 74(2):488-95. PubMed ID: 6086714 [TBL] [Abstract][Full Text] [Related]
5. Anti-thyroglobulin anti-idiotypic antibodies in sera of patients with Hashimoto's thyroiditis and Graves' disease. Sikorska HM J Immunol; 1986 Dec; 137(12):3786-95. PubMed ID: 3782795 [TBL] [Abstract][Full Text] [Related]
6. In vitro suppression of anti-TSH receptor antibody by autologous anti-idiotypic antibody in patients with Graves' disease. Balázs C; Molnár I Acta Microbiol Immunol Hung; 1995; 42(2):163-9. PubMed ID: 7551709 [TBL] [Abstract][Full Text] [Related]
7. Precipitation of the thyrotropin receptor and identification of thyroid autoantigens using Graves' disease immunoglobulins. Heyma P; Harrison LC J Clin Invest; 1984 Sep; 74(3):1090-7. PubMed ID: 6088581 [TBL] [Abstract][Full Text] [Related]
8. Evidence against the importance in the disease process of antibodies to bovine thyroid-stimulating hormone found in some patients with Graves' disease. Noh J; Hamada N; Saito H; Oyanagi H; Ishikawa N; Momotani N; Ito K; Morii H J Clin Endocrinol Metab; 1989 Jan; 68(1):107-13. PubMed ID: 2909548 [TBL] [Abstract][Full Text] [Related]
9. A novel hypothesis for the etiology of Graves' disease: TSAb may be thyroid stimulating animal IgG-like hormone and TBAb may be the precursor of TSAb. Ochi Y; Kajita Y; Hachiya T; Hamaoki M Med Hypotheses; 2012 Jun; 78(6):781-6. PubMed ID: 22472575 [TBL] [Abstract][Full Text] [Related]
10. Molecular analysis of stimulatory anti-thyrotropin receptor antibodies (TSAbs) involved in Graves' disease. Isolation and reconstruction of antibody genes, and production of monoclonal TSAbs. Akamizu T; Matsuda F; Okuda J; Li H; Kanda H; Watanabe T; Honjo T; Mori T J Immunol; 1996 Oct; 157(7):3148-52. PubMed ID: 8816426 [TBL] [Abstract][Full Text] [Related]
11. Use of cells expressing the human thyrotropin (TSH) receptor for the measurement of thyroid stimulating and TSH-blocking antibodies. Vitti P; Chiovato L; Fiore E; Mammoli C; Rocchi R; Pinchera A Acta Med Austriaca; 1996; 23(1-2):52-6. PubMed ID: 8767515 [TBL] [Abstract][Full Text] [Related]
12. Detection of tsh binding inhibiting antibodies (TBI-ab) and thyroid adenylate cyclase stimulating antibodies (TS-ab) in sera of patients with Graves' disease. Lattanzi V; Scardapane R; Ciampolillo A; Vincenti C; Giorgino R Boll Soc Ital Biol Sper; 1985 Jan; 61(1):55-60. PubMed ID: 3838478 [TBL] [Abstract][Full Text] [Related]
13. Ability of monoclonal antibodies to the thyrotropin receptor to increase collagen synthesis in human fibroblasts: an assay which appears to measure exophthalmogenic immunoglobulins in Graves' sera. Rotella CM; Zonefrati R; Toccafondi R; Valente WA; Kohn LD J Clin Endocrinol Metab; 1986 Feb; 62(2):357-67. PubMed ID: 2416769 [TBL] [Abstract][Full Text] [Related]
14. Sensitive thyroid-stimulating antibody assay with high concentrations of polyethylene glycol for the diagnosis of Graves' disease. Takasu N; Kamijo K; Sato Y; Yoshimura H; Nagata A; Ochi Y Clin Exp Pharmacol Physiol; 2004; 31(5-6):314-9. PubMed ID: 15191404 [TBL] [Abstract][Full Text] [Related]
15. Soluble intercellular adhesion molecule-1 (sICAM-1) in Graves' disease. Balázs C; Kiss E Acta Microbiol Immunol Hung; 1994; 41(4):451-6. PubMed ID: 7866729 [TBL] [Abstract][Full Text] [Related]
16. TSH-receptor autoantibodies - differentiation of hyperthyroidism between Graves' disease and toxic multinodular goitre. Wallaschofski H; Kuwert T; Lohmann T Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):171-4. PubMed ID: 15127319 [TBL] [Abstract][Full Text] [Related]
17. Direct binding of thyrotropin receptor autoantibody to in vitro translated thyrotropin receptor: a comparison to radioreceptor assay and thyroid stimulating bioassay. Morgenthaler NG; Hodak K; Seissler J; Steinbrenner H; Pampel I; Gupta M; McGregor AM; Scherbaum WA; Banga JP Thyroid; 1999 May; 9(5):466-75. PubMed ID: 10365678 [TBL] [Abstract][Full Text] [Related]
18. Soluble interleukin-2 receptor in sera of patients with Graves' disease. Balázs C; Farid NR Acta Med Hung; 1991; 48(1-2):3-11. PubMed ID: 1813855 [TBL] [Abstract][Full Text] [Related]
19. Extracts and auto-oxidized constituents of certain plants inhibit the receptor-binding and the biological activity of Graves' immunoglobulins. Auf'mkolk M; Ingbar JC; Kubota K; Amir SM; Ingbar SH Endocrinology; 1985 May; 116(5):1687-93. PubMed ID: 2985357 [TBL] [Abstract][Full Text] [Related]
20. [New assays of TSH-receptor antibodies: analytical and clinical performances in the diagnosis of Graves' disease]. Massart C; Sapin R; Gibassier J; Agin A; d'Herbomez M Ann Biol Clin (Paris); 2009; 67(6):661-7. PubMed ID: 19939769 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]